{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:30Z","timestamp":1772166330068,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Struma ovarii refers to rare mature cystic teratomas containing at least 50% of thyroid tissue, and malignant transformation is known to be even rarer. The synchronous development of malignant struma ovarii and cervical thyroid carcinoma are also scarce and poorly understood due to limited data about molecular features. Here, we present the first report of RET\/PTC 1 rearrangement in synchronous metastatic malignant struma ovarii to the abdominal wall and cervical thyroid cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We described a 47-year-old multigravida woman with bilateral adnexal and lower abdominal wall masses detected during the evaluation of abnormal uterine bleeding. The patient underwent a hysterectomy, bilateral salpingo-oophorectomy, and surgical removal of abdominal wall mass. Then, the pathological evaluation revealed papillary thyroid carcinoma (PTC) within struma ovarii and metastatic PTC in the abdominal wall fibro adipose tissue. Further, cervical thyroid gland physical examination and ultrasound illustrated a nodule within the left lobe. Subsequently, a total thyroidectomy was performed, and a histological examination revealed PTC. Furthermore, all affected tissue, i.e., struma ovarii, abdominal wall metastasis, and cervical thyroid gland tested for BRAF and RAS mutations and RET\/PTC 1 rearrangement. RET\/PTC 1 rearrangement was identified among all three different sites. Finally, after six years of follow-up, the patient had no evidence of recurrence or distant metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In light of these findings, malignant struma ovarii might yield a clue to cervical thyroid carcinoma, and the molecular analysis could provide valuable information for understanding the underlying mechanism, tumor clinicopathological behaviors, and prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13044-023-00181-5","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:02:59Z","timestamp":1695808979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RET\/PTC rearrangement in papillary thyroid carcinoma arising in malignant struma ovarii with abdominal wall metastasis and cervical thyroid gland: a case report and review of the literature"],"prefix":"10.1186","volume":"16","author":[{"given":"Maryam","family":"Kabootari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Habibi Tirtashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita","family":"Zadeh-Vakili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Zarkesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Samadanifard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atieh","family":"Amouzegar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"issue":"2","key":"181_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0002-9378(16)37681-5","volume":"70","author":"WF Peterson","year":"1955","unstructured":"Peterson WF, Prevost EC, Edmunds FT, Hundley JM Jr, Morris FK. Benign cystic teratomas of the ovary: a clinico-statistical study of 1,007 cases with a review of the literature. Am J Obstet Gynecol. 1955;70(2):368\u201382.","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"181_CR2","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1210\/jc.2013-1782","volume":"98","author":"A Leong","year":"2013","unstructured":"Leong A, Roche PJ, Paliouras M, Rochon L, Trifiro M, Tamilia M. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma. J Clin Endocrinol Metabolism. 2013;98(12):4599\u2013605.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"6","key":"181_CR3","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00404-019-05329-z","volume":"300","author":"MR Siegel","year":"2019","unstructured":"Siegel MR, Wolsky RJ, Alvarez EA, Mengesha BM. Struma ovarii with atypical features and synchronous primary thyroid cancer: a case report and review of the literature. Arch Gynecol Obstet. 2019;300(6):1693\u2013707.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"181_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12022-015-9396-1","volume":"26","author":"S Wei","year":"2015","unstructured":"Wei S, Baloch ZW, LiVolsi VA. Pathology of struma ovarii: a report of 96 cases. Endocr Pathol. 2015;26(4):342\u20138.","journal-title":"Endocr Pathol"},{"key":"181_CR5","first-page":"546","volume":"11","author":"Y Cui","year":"2021","unstructured":"Cui Y, Yao J, Wang S, Zhao J, Dong J, Liao L. The clinical and pathological characteristics of malignant struma Ovarii: an analysis of 144 published patients. Front Oncol. 2021;11:546.","journal-title":"Front Oncol"},{"issue":"9","key":"181_CR6","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1111\/jog.14902","volume":"47","author":"S Ayhan","year":"2021","unstructured":"Ayhan S, Kilic F, Ersak B, Aytekin O, Akar S, Turkmen O, et al. Malignant struma ovarii: from case to analysis. J Obstet Gynecol Res. 2021;47(9):3339\u201351.","journal-title":"J Obstet Gynecol Res"},{"issue":"4","key":"181_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/thy.2011.0162","volume":"22","author":"JL Marti","year":"2012","unstructured":"Marti JL, Clark VE, Harper H, Chhieng DC, Sosa JA, Roman SA. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases. Thyroid. 2012;22(4):400\u20136.","journal-title":"Thyroid"},{"issue":"8","key":"181_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1210\/js.2018-00132","volume":"2","author":"CJ Gomes-Lima","year":"2018","unstructured":"Gomes-Lima CJ, Nikiforov YE, Lee W, Burman KD. Synchronous independent papillary thyroid carcinomas in struma ovarii and the thyroid gland with different RAS mutations. J Endocr Soc. 2018;2(8):944\u20138.","journal-title":"J Endocr Soc"},{"issue":"1","key":"181_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07763-8","volume":"21","author":"S Li","year":"2021","unstructured":"Li S, Yang T, Xiang Y, Li X, Zhang L, Deng S. Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary. BMC Cancer. 2021;21(1):1\u201310.","journal-title":"BMC Cancer"},{"issue":"5","key":"181_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/PGP.0000000000000275","volume":"35","author":"D Ma","year":"2016","unstructured":"Ma D, Guseva NV, Dahmoush L, Robinson RA. Struma ovarii with malignant transformation and germline KIT mutation: a case report with review of the literature. Int J Gynecol Pathol. 2016;35(5):442\u20137.","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"181_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1210\/js.2017-00052","volume":"1","author":"RJ Middelbeek","year":"2017","unstructured":"Middelbeek RJ, O\u2019Neill BT, Nishino M, Pallotta JA. Concurrent intrathyroidal thyroid cancer and thyroid cancer in struma ovarii: a case report and literature review. J Endocr Soc. 2017;1(5):396\u2013400.","journal-title":"J Endocr Soc"},{"key":"181_CR12","doi-asserted-by":"crossref","unstructured":"Tzelepis EG, Barengolts E, Garzon S, Shulan J, Eisenberg Y. Unusual case of malignant struma ovarii and cervical thyroid cancer preceded by ovarian teratoma: case report and review of the literature. Case Reports in Endocrinology. 2019;2019.","DOI":"10.1155\/2019\/7964126"},{"key":"181_CR13","doi-asserted-by":"crossref","unstructured":"Capitao R, Saraiva C, Santos F, Ferrinho C, Roque C, Bello C, et al. editors. Malignant struma ovarii and synchronous tumour of thyroid gland in the same patient: a single pathway for two different tumours? Endocrine Abstracts; 2017.","DOI":"10.1530\/endoabs.49.EP1452"},{"issue":"6","key":"181_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1159\/000512735","volume":"10","author":"S Donato","year":"2021","unstructured":"Donato S, Sim\u00f5es H, Leite V. Malignant struma ovarii with concurrent thyroid Cancer: outcomes during and after pregnancy. Eur Thyroid J. 2021;10(6):523\u20137.","journal-title":"Eur Thyroid J"},{"issue":"4","key":"181_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00404-021-05969-0","volume":"303","author":"S Addley","year":"2021","unstructured":"Addley S, Mihai R, Alazzam M, Dhar S. Malignant struma ovarii: surgical, histopathological and survival outcomes for thyroid-type carcinoma of struma ovarii with recommendations for standardising multi-modal management. A retrospective case series sharing the experience of a single institution over 10 years. Arch Gynecol Obstet. 2021;303(4):863\u201370.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"181_CR16","doi-asserted-by":"publisher","first-page":"e242081","DOI":"10.1136\/bcr-2021-242081","volume":"14","author":"SY Chung","year":"2021","unstructured":"Chung SY, Chi J, Park J, John V, Seetharamu N. Malignant struma ovarii with late recurrence harbouring high microsatellite instability. BMJ Case Reports CP. 2021;14(6):e242081.","journal-title":"BMJ Case Reports CP"},{"key":"181_CR17","doi-asserted-by":"crossref","unstructured":"Zarkesh M, Zadeh-Vakili A, Azizi F, Fanaei SA, Foroughi F, Hedayati M. The association of BRAF V600E mutation with tissue inhibitor of metalloproteinase-3 expression and clinicopathological features in papillary thyroid cancer. Int J Endocrinol Metabolism. 2018;16(2).","DOI":"10.5812\/ijem.56120"},{"issue":"5","key":"181_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/eje.0.1480505","volume":"148","author":"E Puxeddu","year":"2003","unstructured":"Puxeddu E, Moretti S, Giannico A, Martinelli M, Marino C, Avenia N, et al. Ret\/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas. Eur J Endocrinol. 2003;148(5):505\u201314.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"181_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/RLU.0b013e3181708297","volume":"33","author":"ST Lim","year":"2008","unstructured":"Lim ST, Jeong H-J, Chung M-J, Yim C-Y, Sohn M-H. Malignant struma ovarii demonstrated on post-therapy radioiodine scan after total thyroidectomy for papillary thyroid cancer. Clin Nucl Med. 2008;33(6):429\u201331.","journal-title":"Clin Nucl Med"},{"issue":"18","key":"181_CR20","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-05-0891","volume":"11","author":"TD Jones","year":"2005","unstructured":"Jones TD, Wang M, Eble JN, MacLennan GT, Lopez-Beltran A, Zhang S, et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res. 2005;11(18):6512\u20139.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"181_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/path.4696","volume":"239","author":"Z Lu","year":"2016","unstructured":"Lu Z, Sheng J, Zhang Y, Deng J, Li Y, Lu A, et al. Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles. J Pathol. 2016;239(1):72\u201383.","journal-title":"J Pathol"},{"issue":"3","key":"181_CR22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s12020-019-01877-1","volume":"64","author":"X Su","year":"2019","unstructured":"Su X, Chen S, He K, Mao Z, Ruan J, Zhou J, et al. Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerization. Endocrine. 2019;64(3):614\u201321.","journal-title":"Endocrine"},{"issue":"4","key":"181_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrendo.2016.11","volume":"12","author":"C Romei","year":"2016","unstructured":"Romei C, Ciampi R, Elisei R. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat Reviews Endocrinol. 2016;12(4):192.","journal-title":"Nat Reviews Endocrinol"},{"issue":"2","key":"181_CR24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1158\/1078-0432.CCR-08-0933","volume":"15","author":"YC Henderson","year":"2009","unstructured":"Henderson YC, Shellenberger TD, Williams MD, El-Naggar AK, Fredrick MJ, Cieply KM, et al. High rate of BRAF and RET\/PTC dual mutations associated with recurrent papillary thyroid carcinoma. Clin Cancer Res. 2009;15(2):485\u201391.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"181_CR25","doi-asserted-by":"publisher","first-page":"101042831771391","DOI":"10.1177\/1010428317713913","volume":"39","author":"HG Vuong","year":"2017","unstructured":"Vuong HG, Altibi AM, Duong UN, Ngo HT, Pham TQ, Tran HM, et al. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: promising value of TERT promoter mutations and insignificant role of BRAF mutations\u2014a meta-analysis. Tumor Biology. 2017;39(10):1010428317713913.","journal-title":"Tumor Biology"},{"issue":"12","key":"181_CR26","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1089\/thy.2005.15.1355","volume":"15","author":"R Elisei","year":"2005","unstructured":"Elisei R, Romei C, Castagna MG, Lisi S, Vivaldi A, Faviana P, et al. RET\/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration. Thyroid. 2005;15(12):1355\u201361.","journal-title":"Thyroid"},{"issue":"3","key":"181_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12022-007-0022-8","volume":"18","author":"O Boutross-Tadross","year":"2007","unstructured":"Boutross-Tadross O, Saleh R, Asa SL. Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr Pathol. 2007;18(3):182\u20136.","journal-title":"Endocr Pathol"},{"key":"181_CR28","first-page":"CMO","volume":"2","author":"EW Janszen","year":"2008","unstructured":"Janszen EW, Van Doorn HC, Ewing PC, De Krijger RR, De Wilt JH, Kam BL, et al. Malignant struma ovarii: good response after thyroidectomy and 131i ablation therapy. Clin Med Oncol. 2008;2:CMO.","journal-title":"Clin Med Oncol"},{"issue":"10","key":"181_CR29","first-page":"24","volume":"7","author":"I Leite","year":"2013","unstructured":"Leite I, Cunha TM, Figueiredo JP, F\u00e9lix A. Papillary carcinoma arising in struma ovarii versus ovarian metastasis from primary thyroid carcinoma: a case report and review of the literature. J Radiol case Rep. 2013;7(10):24.","journal-title":"J Radiol case Rep"},{"issue":"4","key":"181_CR30","first-page":"243","volume":"28","author":"A Krishnamurthy","year":"2013","unstructured":"Krishnamurthy A, Ramshankar V, Vaidyalingam V, Majhi U. Synchronous papillary carcinoma thyroid with malignant struma ovarii: a management dilemma. Indian J Nuclear Medicine: IJNM: Official J Soc Nuclear Med India. 2013;28(4):243.","journal-title":"Indian J Nuclear Medicine: IJNM: Official J Soc Nuclear Med India"},{"key":"181_CR31","doi-asserted-by":"crossref","unstructured":"Brusca N, Del Duca SC, Salvatori R, D\u2019Agostini A, Cannas P, Santaguida MG et al. A case report of thyroid carcinoma confined to ovary and concurrently occult in the thyroid: is conservative treatment always advised? Int J Endocrinol Metabolism. 2015;13(1).","DOI":"10.5812\/ijem.18220"},{"issue":"4","key":"181_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3109\/09513590.2014.995616","volume":"31","author":"BG Aguilera","year":"2015","unstructured":"Aguilera BG, V\u00e1zquez RG, Herguido NG, Gallego FS, Gonz\u00e1lez EN. The lack of consensus in management of malignant struma ovarii. Gynecol Endocrinol. 2015;31(4):258\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"181_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13044-017-0038-1","volume":"10","author":"JC Boyd","year":"2017","unstructured":"Boyd JC, Williams BA, Rigby MH, Kieser K, Offman S, Shirsat H, et al. Malignant struma ovarii in a 30-year old nulliparous patient. Thyroid Res. 2017;10(1):1\u20134.","journal-title":"Thyroid Res"},{"issue":"1","key":"181_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/01443615.2019.1677582","volume":"41","author":"C Gonz\u00e1lez-Cejudo","year":"2021","unstructured":"Gonz\u00e1lez-Cejudo C, Calder\u00f3n AM, Garc\u00eda-Arreza A, Vieites B, Mart\u00ednez M. Conservative surgical approach of a synchronous malignant ovarian struma and papillary thyroid carcinoma in a postmenopausal woman. J Obstet Gynaecology: J Inst Obstet Gynecol. 2021;41(1):160\u20131.","journal-title":"J Obstet Gynaecology: J Inst Obstet Gynecol"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-023-00181-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-023-00181-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-023-00181-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T22:40:56Z","timestamp":1700260856000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/s13044-023-00181-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["181"],"URL":"https:\/\/doi.org\/10.1186\/s13044-023-00181-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2411233\/v1","asserted-by":"object"}]},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"24 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Shahid Beheshti University of Medical Sciences (Protocol no. IR.SBMU.ENDOCRINE.REC.1395.208) and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Additionally, informed consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}